The Role of Epidermal Primary Cilia in Atopic Dermatitis and Psoriasis

1. Kabashima K. Immunology of the skin: Basic and clinical sciences in skin immune responses. Immunology of the Skin: Basic and Clinical Sciences in Skin Immune Responses. doi:10.1007/978-4-431-55855-2

2. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol. 2009;9(10):679-691. doi:10.1038/nri2622

3. Kabashima K, Honda T, Ginhoux F, Egawa G. The immunological anatomy of the skin. Nat Rev Immunol. 2019;19(1):19-30. doi:10.1038/s41577-018-0084-5

4. Laggner U, Di Meglio P, Perera GK, et al. Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis. J Immunol. 2011;187(5):2783-2793. doi:10.4049/jimmunol.1100804

5. Dijkgraaf FE, Matos TR, Hoogenboezem M, et al. Tissue patrol by resident memory CD8+ T cells in human skin. Nat Immunol. 2019;20(6):756-764. doi:10.1038/s41590-019-0404-3

6. Honda T, Kabashima K. Review Novel concept of iSALT (inducible skin- associated lymphoid tissue) in the elicitation of allergic contact dermatitis. doi:10.2183/pjab.92.20

7. Brandt EB, Sivaprasad U. Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol. 2011;2(3). doi:10.4172/2155-9899.1000110

8. Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003;171(6):3262-3269. doi:10.4049/jimmunol.171.6.3262

9. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol. 2008;128(11):2625-2630. doi:10.1038/jid.2008.111

10. Bernard F-X, Morel F, Camus M, et al. Keratinocytes under Fire of Proinflammatory Cytokines: Bona Fide Innate Immune Cells Involved in the Physiopathology of Chronic Atopic Dermatitis and Psoriasis. J Allergy. 2012;2012:718725. doi:10.1155/2012/718725

11. Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014;14(5):289-301. doi:10.1038/nri3646

12. Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England). 2016;387(10023):1109-1122. doi:10.1016/S0140-6736(15)00149-X

13. Hammad H, Lambrecht BN. Barrier Epithelial Cells and the Control of Type 2 Immunity. Immunity. 2015;43(1):29-40. doi:10.1016/J.IMMUNI.2015.07.007

14. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2009;9(5):437-446. doi:10.1097/ACI.0b013e32832e7d36

15. Nutten S. Atopic Dermatitis: Global Epidemiology and Risk Factors. Ann Nutr Metab. 2015;66(1):8-16. doi:10.1159/000370220

16. Salimi M, Barlow JL, Saunders SP, et al. A role for IL-25 and IL-33–driven type- 2 innate lymphoid cells in atopic dermatitis. J Exp Med. 2013;210(13):2939- 2950. doi:10.1084/jem.20130351

17. Guttman-Yassky E, Suárez-Fariñas M, Chiricozzi A, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol. 2009;124(6). doi:10.1016/j.jaci.2009.09.031

18. Proksch E, Fölster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci. 2006;43(3):159-169. doi:10.1016/j.jdermsci.2006.06.003

19. Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis - Part I: Clinical and pathologic concepts. In: Journal of Allergy and Clinical Immunology. Vol 127. Elsevier Ltd; 2011:1110- 1118. doi:10.1016/j.jaci.2011.01.053

20. Irvine AD, McLean WHI, Leung DYM. Filaggrin Mutations Associated with Skin and Allergic Diseases. N Engl J Med. 2011;365(14):1315-1327. doi:10.1056/NEJMra1011040

21. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983-994. doi:10.1016/S0140-6736(14)61909-7

22. Man XY, Chen XB, Li W, et al. Analysis of epithelial-mesenchymal transition markers in psoriatic epidermal keratinocytes. Open Biol. 2015;5(8). doi:10.1098/rsob.150032

23. Martin DA, Towne JE, Kricorian G, et al. The emerging role of IL-17 in the pathogenesis of psoriasis: Preclinical and clinical findings. J Invest Dermatol. 2013;133(1):17-26. doi:10.1038/jid.2012.194

24. Kurtz E, Jacques SL, Blauvelt Heather Rizzo AL, Kagami S, Phillips KG. Hyperplasia Is Dependent on IL-17A Mediated Psoriasis-Like Epidermal − IL-23. J Immunol. 2011;186:1495-1502. doi:10.4049/jimmunol.1001001

25. De Benedetto A, Kubo A, Beck LA. Skin Barrier Disruption: A Requirement for Allergen Sensitization? J Invest Dermatol. 2012;132:949-963. doi:10.1038/jid.2011.435

26. Castex-Rizzi N, Galliano MF, Aries MF, et al. In vitro approaches to pharmacological screening in the field of atopic dermatitis. Br J Dermatol. 2014;170(SUPPL. 1):12-18. doi:10.1111/bjd.13106

27. Bochénska K, Smolińska E, Moskot M, Jakóbkiewicz-Banecka J, Gabig- Cimińska M. Models in the research process of psoriasis. Int J Mol Sci. 2017;18(12). doi:10.3390/ijms18122514

28. Deyrieux AF, Wilson VG. In vitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology. 2007;54(2):77-83. doi:10.1007/s10616-007-9076-1

29. Ezratty E, Stokes N, Chai S, Shah A, Williams S, Fuchs E. Differentiation During Skin Development. Cell. 2011;145(7):1129-1141. doi:10.1016/j.cell.2011.05.030.A

30. Wheway G, Nazlamova L, Hancock JT. Signaling through the Primary Cilium. Front Cell Dev Biol. 2018;6:8. doi:10.3389/FCELL.2018.00008

31. Croyle MJ, Lehman JM, O’Connor AK, et al. Role of epidermal primary cilia in the homeostasis of skin and hair follicles. J Cell Sci. 2011;124(9):e1-e1. doi:10.1242/jcs.091256

32. Irigoin F, L. Badano J. Keeping the Balance Between Proliferation and Differentiation:The Primary Cilium. Curr Genomics. 2011;12(4):285-297. doi:10.2174/138920211795860134

33. Wann AKT, Chapple JP, Knight MM. The primary cilium influences interleukin- 1β-induced NFκB signalling by regulating IKK activity. Cell Signal. 2014;26(8):1735-1742. doi:10.1016/j.cellsig.2014.04.004

34. Baek H, Shin HJ, Kim J-J, et al. Primary cilia modulate TLR4-mediated inflammatory responses in hippocampal neurons. J Neuroinflammation. 2017;14(1):189. doi:10.1186/s12974-017-0958-7

35. Toriyama M, Rizaldy D, Nakamura M, et al. Immunological role of primary cilia of dendritic cells in human skin disease. bioRxiv. January 2020:2020.02.04.933333. doi:10.1101/2020.02.04.933333

36. Wong SY, Seol AD, So PL, et al. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med. 2009;15(9):1055-1061. doi:10.1038/nm.2011

37. Sipos É, Komoly S, Ács P. Quantitative Comparison of Primary Cilia Marker Expression and Length in the Mouse Brain. J Mol Neurosci. 2018;64(3):397-409. doi:10.1007/s12031-018-1036-z

38. Thorpe SD, Gambassi S, Thompson CL, Chandrakumar C, Santucci A, Knight MM. Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria. J Cell Physiol. 2017;232(9):2407-2417. doi:10.1002/jcp.25839

39. Ritter A, Friemel A, Kreis NN, et al. Primary Cilia Are Dysfunctional in Obese Adipose-Derived Mesenchymal Stem Cells. Stem Cell Reports. 2018;10(2):583- 599. doi:10.1016/j.stemcr.2017.12.022

40. Blanpain C, Fuchs E. Epidermal Stem Cells of the Skin. Annu Rev Cell Dev Biol. 2006;22(1):339-373. doi:10.1146/annurev.cellbio.22.010305.104357

41. Castex-Rizzi N, Galliano MF, Aries MF, et al. In vitro approaches to pharmacological screening in the field of atopic dermatitis. Br J Dermatol. 2014;170:12-18. doi:10.1111/bjd.13106

42. Welss T, Basketter DA, Schröder KR. In vitro skin irritation: Facts and future. State of the art review of mechanisms and models. Toxicol Vitr. 2004;18(3):231- 243. doi:10.1016/j.tiv.2003.09.009

43. Van Den Bogaard EH, Tjabringa GS, Joosten I, et al. Crosstalk between keratinocytes and T cells in a 3D microenvironment: A model to study inflammatory skin diseases. J Invest Dermatol. 2014;134(3):719-727. doi:10.1038/jid.2013.417

44. Delaval B, Bright A, Lawson N, Doxsey S. The cilia protein IFT88 is required for spindle orientation in mitosis. Nat Cell Biol. 2011;13(4):461-468. doi:10.1038/ncb2202.The

45. Boehlke C, Janusch H, Hamann C, et al. A cilia independent role of Ift88/polaris during cell migration. PLoS One. 2015;10(10):1-19. doi:10.1371/journal.pone.0140378

46. Choi YJ, Laclef C, Yang N, et al. RPGRIP1L is required for stabilizing epidermal keratinocyte adhesion through regulating desmoglein endocytosis. PLoS Genet. 2019;15(1). doi:10.1371/journal.pgen.1007914

47. Mirvis M, Stearns T, Nelson WJ. Cilium structure, assembly, and disassembly regulated by the cytoskeleton. Biochem J. 2018;475(14):2329-2353. doi:10.1042/BCJ20170453

48. Ezratty EJ, Stokes N, Chai S, Shah AS, Williams SE, Fuchs E. A Role for the Primary Cilium in Notch Signaling and Epidermal Differentiation during Skin Development. Cell. 2011;145(7):1129-1141. doi:10.1016/J.CELL.2011.05.030

49. Robert A, Margall-Ducos G, Guidotti J-E, et al. The intraflagellar transport component IFT88/polaris is a centrosomal protein regulating G1-S transition in non-ciliated cells. J Cell Sci. 2007;120:918. doi:10.1242/jcs.03422

50. Tsoi LC, Rodriguez E, Degenhardt F, et al. Atopic Dermatitis Is an IL-13- Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis. J Invest Dermatol. 2019;139(7):1480-1489. doi:10.1016/j.jid.2018.12.018

51. McAleer MA, Pohler E, Smith FJD, et al. Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin. J Allergy Clin Immunol. 2015;136(5):1268-1276. doi:10.1016/j.jaci.2015.05.002

52. de Sousa VB, Santana CNL e. L, Pereira D do N, Gripp AC. Pemphigus foliaceus with pustular presentation in a patient with psoriasis. An Bras Dermatol. 2017;92(5):115-117. doi:10.1590/abd1806-4841.20175709

53. Rangarajan A, Talora C, Okuyama R, et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 2001;20(13):3427-3436. doi:10.1093/emboj/20.13.3427

54. Calautti E, Li J, Saoncella S, Brissette JL, Goetinck PF. Phosphoinositide 3- kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem. 2005;280(38):32856-32865. doi:10.1074/jbc.M506119200

55. Samuelov L, Sarig O, Harmon RM, et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet. 2013;45(10):1244-1248. doi:10.1038/ng.2739

56. Ezratty EJ, Pasolli HA, Fuchs E. A Presenilin-2-ARF4 trafficking axis modulates Notch signaling during epidermal differentiation. J Cell Biol. 2016;214(1):89- 101. doi:10.1083/jcb.201508082

57. De Andrea CE, Wiweger M, Prins F, Bovée JVMG, Romeo S, Hogendoorn PCW. Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma. Lab Investig. 2010;90(7):1091-1101. doi:10.1038/labinvest.2010.81

58. Dai D, Li L, Huebner A, et al. Planar cell polarity effector gene Intu regulates cell fate-specific differentiation of keratinocytes through the primary cilia. Cell Death Differ. 2013;20(1):130-138. doi:10.1038/cdd.2012.104

59. Hua K, Ferland RJ. Fixation methods can differentially affect ciliary protein immunolabeling. Cilia. 2017;6(1):5. doi:10.1186/s13630-017-0045-9

60. Noda S, Suárez-Fariñas M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol. 2015;136(5):1254-1264. doi:10.1016/j.jaci.2015.08.015

61. El-Abaseri TB, Putta S, Hansen LA. Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis. 2006;27(2):225-231. doi:10.1093/carcin/bgi220

62. Christensen ST, Clement CA, Satir P, Pedersen LB. Primary cilia and coordination of receptor tyrosine kinase (RTK) signalling. J Pathol. 2012;226(2):172-184. doi:10.1002/path.3004

63. Inoko A, Matsuyama M, Goto H, et al. Trichoplein and Aurora A block aberrant primary cilia assembly in proliferating cells. J Cell Biol. 2012;197(3):391-405. doi:10.1083/jcb.201106101

64. Lee CW, Lin ZC, Hu SCS, et al. Urban particulate matter down-regulates filaggrin via COX2 expression/PGE2 production leading to skin barrier dysfunction. Sci Rep. 2016;6(1):1-16. doi:10.1038/srep27995

65. Eckert RL, Efimova T, Dashti SR, et al. Keratinocyte survival, differentiation, and death: Many roads lead to mitogen-activated protein kinase. In: Journal of Investigative Dermatology Symposium Proceedings. Vol 7. Blackwell Publishing Inc.; 2002:36-40. doi:10.1046/j.1523-1747.2002.19634.x

66. Kim BE, Leung DYM, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008;126(3):332-337. doi:10.1016/j.clim.2007.11.006

67. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120(1):150-155. doi:10.1016/j.jaci.2007.04.031

68. Howell MD, Fairchild HR, Kim BE, et al. Th2 Cytokines Act on S100/A11 to Downregulate Keratinocyte Differentiation. J Invest Dermatol. 2008;128(9):2248-2258. doi:10.1038/JID.2008.74

69. Boniface K, Bernard F-X, Garcia M, Gurney AL, Lecron J-C, Morel F. IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes. J Immunol. 2005;174(6):3695-3702. doi:10.4049/jimmunol.174.6.3695

70. Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008;159(5):1092-1102. doi:10.1111/j.1365- 2133.2008.08769.x

71. Hänel KH, Cornelissen C, Lüscher B, Baron JM. Cytokines and the skin barrier. Int J Mol Sci. 2013;14(4):6720-6745. doi:10.3390/ijms14046720

72. Noske K. Secreted immunoregulatory proteins in the skin. J Dermatol Sci. 2018;89(1):3-10. doi:10.1016/j.jdermsci.2017.10.008

73. Weston CR, Wong A, Hall JP, Goad MEP, Flavell RA, Davis RJ. The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis. Proc Natl Acad Sci U S A. 2004;101(39):14114- 14119. doi:10.1073/pnas.0406061101

74. Gruber R, Börnchen C, Rose K, et al. Diverse Regulation of Claudin-1 and Claudin-4 in Atopic Dermatitis. Am J Pathol. 2015;185(10):2777-2789. doi:10.1016/J.AJPATH.2015.06.021

75. Oji V, Eckl KM, Aufenvenne K, et al. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: Unraveling the peeling skin disease. Am J Hum Genet. 2010;87(2):274-281. doi:10.1016/j.ajhg.2010.07.005

76. Allen M, Ishida-Yamamoto A, Mcgrath J, et al. Corneodesmosin Expression in Psoriasis Vulgaris Differs from Normal Skin and Other Inflammatory Skin Disorders.; 2001.

77. Jiménez-Martínez M, Stamatakis K, Fresno M. The dual-specificity phosphatase 10 (DUSP10): Its role in cancer, inflammation, and immunity. Int J Mol Sci. 2019;20(7). doi:10.3390/ijms20071626

78. Gazel A, Banno T, Walsh R, Blumenberg M. Inhibition of JNK promotes differentiation of epidermal keratinocytes. J Biol Chem. 2006;281(29):20530- 20541. doi:10.1074/jbc.M602712200

79. Hammers CM, Stanley JR. Desmoglein-1, differentiation, and disease. J Clin Invest. 2013;123(4):1419-1422. doi:10.1172/JCI69071

80. Sotiropoulou PA, Blanpain C. Development and homeostasis of the skin epidermis. Cold Spring Harb Perspect Biol. 2012;4(7):1-9. doi:10.1101/cshperspect.a008383

81. Morizane S, Yamasaki K, Kajita A, et al. TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. J Allergy Clin Immunol. 2012;130(1):259. doi:10.1016/j.jaci.2012.03.006

82. Pastore S, Giustizieri ML, Mascia F, Giannetti A, Kaushansky K, Girolomoni G. Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. J Invest Dermatol. 2000;115(6):1134-1143. doi:10.1046/j.1523-1747.2000.00149.x

83. You H, Padmashali RM, Ranganathan A, et al. JNK regulates compliance- induced adherens junctions formation in epithelial cells and tissues. doi:10.1242/jcs.122903

84. Schumacher M, Schuster C, Rogon ZM, et al. Efficient keratinocyte differentiation strictly depends on JNK-induced soluble factors in fibroblasts. J Invest Dermatol. 2014;134(5):1332-1341. doi:10.1038/jid.2013.535

85. Hammouda MB, Ford AE, Liu Y, Zhang JY. The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer. Cells. 2020;9(4):857. doi:10.3390/cells9040857

86. Choi J, Kim JR, Kim H, et al. The atopic dermatitis-like symptoms induced by MC903 were alleviated in JNK1 knockout mice. Toxicol Sci. 2013;136(2):443- 449. doi:10.1093/toxsci/kft215

87. Takahashi H, Ibe M, Nakamura S, Ishida-Yamamoto A, Hashimoto Y, Iizuka H. Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci. 2002;30(2):94-99. doi:10.1016/S0923-1811(02)00064-6